Potential Treatments for SARS-CoV-2 Beyond Current and Related New-Generation Antivirals and Monoclonal Antibodies

Apr 2, 2025 by in PUBLIC HEALTH AND EPIDEMIOLOGY Comments Off on Potential Treatments for SARS-CoV-2 Beyond Current and Related New-Generation Antivirals and Monoclonal Antibodies

Potential Treatments for SARS-CoV-2 Beyond Current and Related New-Generation Antivirals and Monoclonal Antibodies Roberto Patarca William A. Haseltine INTRODUCTION Available vaccines, monoclonal antibodies, and antivirals for severe acute respiratory syndrome…

read more

T Cells and COVID-19

Apr 2, 2025 by in PUBLIC HEALTH AND EPIDEMIOLOGY Comments Off on T Cells and COVID-19

T Cells and COVID-19 Shiv Pillai INTRODUCTION: T-CELL RESPONSES TO VIRUSES When one considers immune responses to viruses in general, there is broad acceptance, largely based on studies on rodents…

read more

Pediatric COVID

Apr 2, 2025 by in PUBLIC HEALTH AND EPIDEMIOLOGY Comments Off on Pediatric COVID

Pediatric COVID Anna Martens Lael Yonker INTRODUCTION During the early phases of the coronavirus disease 2019 (COVID-19) pandemic, hospitals were inundated with adults infected with severe acute respiratory syndrome coronavirus…

read more

Long COVID

Apr 2, 2025 by in PUBLIC HEALTH AND EPIDEMIOLOGY Comments Off on Long COVID

Long COVID Roberto Patarca INTRODUCTION Beyond the human toll of its acute-phase and devastating socioeconomic impact, the still lingering severe acute respiratory syndrome (SARS)-coronavirus (CoV)-2 pandemic1,2 that started toward the…

read more

SARS-CoV-2 Variants

Apr 2, 2025 by in PUBLIC HEALTH AND EPIDEMIOLOGY Comments Off on SARS-CoV-2 Variants

SARS-CoV-2 Variants Jacob E. Lemieux Jeremy Luban INTRODUCTION Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants are clusters of mutations that create distinct genetic lineages of SARS-CoV-2. Several such lineages…

read more
Get Clinical Tree app for offline access